Norway· NO-ID_41269922-DE70-4A11-8210-5A579D6003F9
Arexvy
A respiratorisches-synzytial-virus impfstoffe product containing stimulon + respiratory syncytial virus + glycoprotein f + recombinant + stabilised in the pre-fusion conformation + adjuvanted with as01e + 3-o-desacyl-4'-monophosphoryl lipid a, registered in Norway by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against FEST (Norway) on
Informational only — not a medical device.
Where it is registered
Respiratorisches-synzytial-virus impfstoffe is registered in 11 of 19 countries.
Countries holding a registration under ATC J07BX05 (respiratorisches-synzytial-virus impfstoffe), each read from that country’s own register.
- This record: Norway, from FEST (Norway)
- 7 of them publish a price we can compare per daily dose
Respiratorisches-synzytial-virus impfstoffe · ATC J07BX05
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
FEST (Norway)- Active substance
- Stimulon + Respiratory Syncytial Virus + Glycoprotein F + Recombinant + Stabilised In The Pre-Fusion Conformation + Adjuvanted With As01e + 3-O-Desacyl-4'-Monophosphoryl Lipid A
- Manufacturer
- GlaxoSmithKline Biologicals S.A.
- Country
- Norway (NO)
- ATC code
- J07BX05
- ATC class
- Respiratorisches-Synzytial-Virus Impfstoffe
- Reimbursed
- Not published by this register
- Source register
- FEST (Norway)
- Last checked
- September 25, 2026
Packs & prices · 3
1 priced- no_merkevare_idID_41269922-DE70-4A11-8210-5A579D6003F9
- no_varenummer0413121NOK 2342.5
- gtin5050459004499
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07BX05
Respiratorisches-synzytial-virus impfstoffe, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/afa6f792-f14a-484f-9c22-238fe640622b GET /v1/drugs/afa6f792-f14a-484f-9c22-238fe640622b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Pulver og suspensjon til injeksjonsvæske, suspensjon",
"source": "fest",
"status": "A",
"atc_name": "Respiratoriske syncytialvirusvaksiner",
"merkevare_id": "ID_41269922-DE70-4A11-8210-5A579D6003F9",
"name_form_strength": "Arexvy pulv+susp til inj susp 120 mikrog/hetteglass",
"prescription_group": "C"
}See everything about respiratorisches-synzytial-virus impfstoffe.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.